Shifting from individual treatment to treatment of the population.
Kozma
Chris M
CM
Pharmaceutical Outcomes Consultant, West Columbia, South Carolina, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy; D006801:Humans; D014481:United States
D000806:Angiotensin-Converting Enzyme Inhibitors